Top Markets
Coin of the day
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.

INFI
Rang in aandelen #40134
Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge,... Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.
Aandeelprijs
$0.0039
Laatst gesynchroniseerd: 2023-10-27
Marktkapitalisatie
$235.97K
Verandering (1 dag)
-13.33%
Verandering (1 jaar)
0.00%
Land
US
Handel Infinity Pharmaceuticals, Inc. (INFI)

Categorie

Koersgeschiedenis voor Infinity Pharmaceuticals, Inc. (INFI)
Hoogste slotkoers: $0.01 op 2023-10-01

Laagste slotkoers: $73.13 op 2000-07-01
Koersgeschiedenis van Infinity Pharmaceuticals, Inc. van 2000 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2023 -98.96%
2022 -78.38%
2021 8.32%
2020 89.72%
2019 -2.65%
2018 -38.84%
2017 43.17%
2016 -82.79%
2015 -52.89%
2014 22.59%
2013 -54.04%
2012 217.20%
2011 50.43%
2010 3.86%
2009 -21.32%
2008 -21.62%
2007 -22.40%
2006 27.00%
2005 -47.59%
2004 -19.50%
2003 93.27%
2002 -54.89%
2001 -34.73%
2000 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.09%
KR
$259.89 14.81%
BE